Strong Correlation of B₂-Microglobulin (B₂-m) with Procalcitonin (PCT) in the Serum of Chronic Hemodialysis Patients: A Role for Infections in the Dialysis-Related Amyloidosis?

REFERENCES

• Drueke TB. Dialysis-related amyloidosis. Nephrol Dial Transplant. 1998; 13: 58–64
   PubMedGoogle Scholar
• Dember LM, Jaber BL. Dialysis-related amyloidosis: Late finding or hidden epidemic?. Semin Dial. 2006; 19: 105–109
   PubMedGoogle Scholar
• Jofre R, Rodriguez-Benitez P, Lopez-Gomez JM, et al. Inflammatory syndrome in patients on hemodialysis. J Am Soc Nephrol 2006; 17: S274–S280
   PubMedGoogle Scholar
• Yao Q, Axelsson J, Stevinkel P, et al. Chronic systemic inflammation in dialysis patients: An update on causes and consequences. ASAIO J. 2004; 50: Iiii–Ivii
   Google Scholar
• Oberhoffer M, Vogelsang H, Jager L, et al. Katacalcin and calcitonin immunoreactivity in different types of leucocytes indicate intracellular procalcitonin content. J Crit Care. 1999; 14: 29–33
   PubMed Web of Science ®Google Scholar
• Russwurm S, Wiederhold M, Oberhoffer M, et al. Molecular aspects and natural source of procalcitonin. Clin Chem Lab Med. 1999; 37: 789–797
   PubMed Web of Science ®Google Scholar
• Castelli GP, Pognani C, Meisner M, et al. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Critical Care. 2004; 8: R234–R242
   PubMed Web of Science ®Google Scholar
• Rothenburger M, Markewitz A, Lenz T, et al. Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein. Clin Chem Lab Med. 1999; 37: 275–279
   PubMed Web of Science ®Google Scholar
• Falcoz PE, Laluc F, Toubin MM, et al. Usefulness of procalcitonin in the early detection of infection after thoracic surgery. Eur J Cardiothorac Surg. 2005; 27: 1074–1078
   PubMed Web of Science ®Google Scholar
• Eberhard OK, Haubitz M, Brunkhorst FM, et al. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus / systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum. 1997; 40: 1250–1256
   PubMed Web of Science ®Google Scholar
• Stevinkel P, Lindholm B. C-reactive protein in end stage renal disease: Are there reasons to measure it?. Blood Purif. 2005; 23: 72–78
   PubMedGoogle Scholar
• Rao M, Jaber BL, Balakrishnan VS. Inflammatory biomarkers and cardiovascular risk: Association or cause and effect?. Semin Dial. 2006; 19: 129–135
   PubMed Web of Science ®Google Scholar
• Herget-Rosenthal S, Margraff G, Pietruck F, et al. Procalcitonin for accurate detection of infection in hemodialysis. Nephrol Dial Transplant. 2001; 16: 975–979
   PubMed Web of Science ®Google Scholar
• Chauveau P, Level C, Lasseur C, et al. C-reactive protein and procalcitonin as markers of mortality in hemodialysis patients: A two-year prospective study. J Ren Nutr. 2003; 13: 137–143
   PubMedGoogle Scholar
• Steinbach G, Bolke E, Grunert A, et al. Procalcitonin in patients with acute and chronic renal insufficiency. Wien Klin Wochenschr. 2004; 116: 849–853
   PubMed Web of Science ®Google Scholar
• Sitter T, Schmidt M, Schneider S, et al. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin. J Nephrol 2005; 15: 297–301
   Google Scholar
• Visvardis G, Griveas I, Fleva A, et al. Relevance of procalcitonin levels in comparison to other markers of inflammation in hemodialysis patients. Ren Fail. 2005; 27: 429–434
   PubMed Web of Science ®Google Scholar
• Level C, Chauveau P, Delmas Y, et al. Procalcitonin: A new marker of inflammation in hemodialysis patients?. Nephrol Dial Transplant. 2001; 16: 980–986
   PubMed Web of Science ®Google Scholar
• Conti G, Amore A, Chiesa M, et al. Procalcitonin as a marker of micro-inflammation in hemodialysis. J Nephrol. 2005; 18: 282–288
   PubMedGoogle Scholar
• Herget-Rosenthal S, Margraff G, Pietruck F, et al. Procalcitonin for accurate detection of infection in hemodialysis. Nephrol Dial Transplant. 2001; 16: 975–979
   PubMed Web of Science ®Google Scholar
• Dahaba AA, Rehak PH, List WF. Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis. Intensive Care Med. 2003; 29: 579–583
   PubMed Web of Science ®Google Scholar
• Schmidt M, Burchardi C, Sitter T, et al. Procalcitonin in patients undergoing chronic hemodialysis. Nephron 2000; 84: 187–188
   PubMed Web of Science ®Google Scholar
• Delevaux I, Andre M, Colombier M, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?. Ann Rheum Dis 2003; 62: 337–340
   PubMed Web of Science ®Google Scholar
• Kumano K, Nanbu M, Kusakari S, et al. Beta-2 microglobulin synthesis of mononuclear cells in chronic dialysis patients. Int J Artif Organs. 1992; 15: 401–407
   PubMedGoogle Scholar
• Vraetz T, Ittel TH, Mackelenbergh MG, et al. Regulation of b2 microglobulin expression in different human cell lines by proinflammatory cytokines. Nephrol Dial Transplant. 1999; 14: 2137–2143
   PubMedGoogle Scholar
• Herget-Rosenthal S, Klein T, Margraff T, et al. Modulation and source of procalcitonin in reduced renal function and renal replacement therapy. Scand J Immunol 2005; 61: 180–186
   PubMed Web of Science ®Google Scholar
• Lorton F, Veinberg F, Lelsch D, et al. Procalcitonin serum levels in children undergoing hemodialysis. Pediatr Nephrol. 2007; 22: 430–435
   PubMed Web of Science ®Google Scholar
• Kafkas N, Venetsanou K, Patsilinakos S, et al. Procalcitonin in acute myocardial infarction. Acute Card Care. 2007; 8: 1–7
   Google Scholar